Coaching and contributing capital
Growing a start-up is a long, iterative and collaborative process— particularly in the life sciences, where failure rates are high despite the significant human and financial resources applied to each company.
Lightstone Singapore chooses to invest in early-stage companies but only those with novel, disruptive and defendable technology where it believes the company’s technology can address unmet clinical needs.
As one of the four distinct funds under Lightstone Ventures, a US-headquartered VC with a footprint in the US, Western Europe and Asia and over US$850 million under management, the Lightstone Venture’s portfolio includes companies in the fields of small molecule drug discovery, cell and gene therapies, therapeutic devices as well as a number of consumer devices.
“By allowing the VC to lay down the operational foundations of the company, first-time scientific founders are able to focus on developing the science, thereby playing to the founder’s overarching strength,” Dr. Noonan explained.
“Ensuring that the company starts its journey on sound scientific footing, coupled with a robust operational foundation and sufficient capital and human resources, significantly improves its chances of success,” he said.
As the biotech space rapidly evolves, it’s clear that company founders and their institutions must foster close collaborations with their lead investors; thereby smoothing the way for a company’s evolution from bench to commercialization.
“There is no better time to be in the biotech space in Singapore,” concluded Dr. Hung. “Having an experienced venture investor as a partner from the earliest stage of Ligature’s evolution gives the founders confidence that Ligature will be successful.”
Interested founders/start-ups in the life sciences industry looking for an early-stage venture capital partner can visit the Lightstone Ventures website for more information about Lightstone Singapore as well as Lightstone Ventures.
Asian Scientist Magazine is a media partner of Lightstone Singapore.
———
Copyright: Asian Scientist Magazine; Photo: Freepik.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.